Etanercept Exacerbates Inflammation and Pathology in a Rabbit Model of Active Pulmonary Tuberculosis-Reference-Cited by-同舟云学术

Etanercept Exacerbates Inflammation and Pathology in a Rabbit Model of Active Pulmonary Tuberculosis

Published:2014-09 Issue:9 Volume:34 Page:716-726
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Tsenova Liana¹²,O'Brien Paul¹,Holloway Jennifer¹,Peixoto Blas¹,Soteropoulos Patricia³,Fallows Dorothy¹,Kaplan Gilla¹,Subbian Selvakumar¹

Affiliation:

1. Laboratory of Mycobacterial Immunity and Pathogenesis, The Public Health Research Institute (PHRI), Rutgers Biomedical and Health Sciences, Rutgers The State University of New Jersey, Newark, New Jersey.

2. Biological Sciences Department, NYC College of Technology, Brooklyn, New York.

3. The Center for Applied Genomics, PHRI, Rutgers Biomedical and Health Sciences, Rutgers The State University of New Jersey, Newark, New Jersey.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jir.2013.0123

Reference54 articles.

1. Tumor Necrosis Factor and Chemokine Interactions in the Formation and Maintenance of Granulomas in Tuberculosis

2. Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy

3. Antirheumatic Drugs and the Risk of Tuberculosis

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies;Seminars in Immunology;2023-01

2. Pathogenetic role of tumor necrosis factor (TNF-α) for the development of peritoneal tuberculosis in an experiment;Acta Biomedica Scientifica;2021-11-23

3. Tumor Necrosis Factor Inhibitors Exacerbate Whipple’s Disease by Reprogramming Macrophage and Inducing Apoptosis;Frontiers in Immunology;2021-05-20

4. Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis;Frontiers in Immunology;2021-04-19

5. One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics;Frontiers in Cellular and Infection Microbiology;2021-03-16